login
login

Europe Daily Bulletin No. 7966

17 May 2001
Contents Publication in full By article 43 / 46
ECONOMIC INTERPENETRATION / (eu) medical

The American pharmaceuticals group JOHNSON AND JOHNSON is well into discussions for the purchase of INVERNESS MEDICAL TECHNOLOGY, specialised in glycaemia tests for diabetics for the sum of $1.3 billion through a share swap. According to the terms of the negotiation, INVERNESS MEDICAL TECHNOLOGY would break away from its activities not linked to diabetes to form a new enterprise quoted on the Stock Exchange

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION
SUPPLEMENT